ClinicalTrials.Veeva

Menu

Language Control Across Modalities

University of California San Diego logo

University of California San Diego

Status

Enrolling

Conditions

Healthy

Treatments

Behavioral: Predictability
Behavioral: language context

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07226921
R01HD116841 (U.S. NIH Grant/Contract)
806634

Details and patient eligibility

About

This study aims to investigate how unimodal bilinguals who speak two languages and bimodal bilinguals who speak one language and sign another control languages across comprehension and production. Participants will complete different language tasks (e.g., classify a word, name a picture) in different languages, and their behavioral performance will be assessed, including accuracy and reaction time.

Enrollment

360 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Proficient in both Mandarin and English, or proficiency in both ASL and English

Exclusion criteria

  • Know a third language better than Mandarin/English or better than ASL/English
  • With language disorder or other neurological disorders

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

360 participants in 4 patient groups

Predictable one-language production & both-language comprehension
Experimental group
Treatment:
Behavioral: language context
Behavioral: Predictability
Predictable both-language production & both-language comprehension
Experimental group
Treatment:
Behavioral: language context
Behavioral: Predictability
Unpredictable one-language production & both-language comprehension
Experimental group
Treatment:
Behavioral: language context
Behavioral: Predictability
Single language comprehension and production
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems